Background: SDF-1/CXCR4 signaling plays key roles in directed cell migration under physiological
Introduction
Stromal cell-derived factor (SDF)-1/CXCL12 belongs to a family of chemoattractant cytokines known as chemokines that interact with CXC chemokine receptor 4 (CXCR4) on various leukocytes [1, 2] . CXCR4-expressing immune cells migrate through an SDF-1 gradient, which is highly secreted from inflammatory tissues, leading to onset of the immune response under physiological conditions [3] . The SDF-1/CXCR4 axis also contributes to the migration of stem/progenitor cells to appropriate locations during embryogenesis and organogenesis, and thus knockdown of the SDF-1 or CXCR4 gene in mice causes embryonic lethality [4, 5] . In addition to these physiological findings, pathological roles of CXCR4 in several diseases have been reported. CXCR4-overexpressing malignant tumor cells metastasize toward distinct organs present in a high level of SDF-1, such as the direction of breast cancer cells toward the lung, liver and bone marrow [6] . CXCR4 also plays an essential role in the entry of human immunodeficiency virus type (HIV)-1 into T cells [7, 8] .
Therefore, CXCR4 is a promising molecular target for anti-metastatic and anti-HIV agents, and for diagnostic agents for CXCR4-expressing malignant tumors [9] [10] [11] [12] [13] . Recently, CXCR7/RDC1 was identified as an alternative receptor for . CXCR7 is also related to cancer progression and HIV infection [15, 16] , and functions as a decoy receptor that does not trigger G-protein-dependent downstream signaling (e.g. calcium flux) upon SDF-1 interaction, unlike the case for CXCR4 [17, 18] .
To fully appreciate the physiological and pathological roles of CXCR4 and CXCR7, tracer-conjugated receptors have been employed for visualization of the receptor localization and trafficking [19, 20] . For example, when a fluorescent protein such as GFP was conjugated to the CXCR4 C-terminus, SDF-1-mediated CXCR4 internalization and homodimer/heterodimer formation were observed by bioluminescence resonance energy transfer and fluorescence resonance energy transfer [21] [22] [23] . In addition, an anti-CXCR4 antibody was applied to the detection of the receptors on cells [24, 25] . Fluorescent CXCR4-selective antagonists including TY14003 have been also for 1 h at room temperature. The reaction mixtures were measured by a TopCount (Packard). Data were analyzed using GraphPad Prism software (GraphPad Software Inc.).
Intracellular calcium mobilization
Calcium mobilization was evaluated by aequorin assay by the Euroscreen FAST service from Euroscreen (Gosselies, Belgium). Briefly, CHO-K1 cells expressing the human recombinant CXCR4, were grown for 18 h prior to the test in media without antibiotics. The cells were detached by gentle flushing with PBS-EDTA (5 mM EDTA), recovered by centrifugation and resuspended in assay buffer (DMEM/F-12 with HEPES + 0.1% BSA protease free). Cells were incubated at room temperature for at least 4 h with coelenterazine h (Molecular Probes). 50 l of cell suspension was injected on 50 l of test compound (200 nM) plated in a 96-well plate. The resulting emission of light was recorded using the Hamamatsu Functional Drug Screening System 6000 (FDSS 6000).
Establishment of Cell Lines
pcDNA5/FRT/TO-CXCR4 and pcDNA5/FRT/TO-CXCR7 were prepared as previously described [11] . Flp-In 293 cells or Flp-In CHO cells (Invitrogen) were maintained in Dulbecco's modified Eagle's medium (Sigma) or F-12 medium (Wako), respectively. These were supplemented with 10% heat-inactivated fetal bovine serum, 100 g/mL zeocin, 100 U/mL penicillin and 100 g/mL streptomycin in 5% CO2 at 37°C. The CXCR4 mutant constructs were cotransfected with pOG44 (Invitrogen), an expression vector for Flp recombinase, into Flp-In 293 cells according to the manufacturer's protocol. The cells were cultured in the above medium in the presence of 100 g/mL hygromycin. The cells showing resistance to hygromycin were selected, and the expression of CXCR4 was examined by flow cytometry as CXCR4-positive cells.
Flow Cytometry Analyses
HEK293 cells with transfection of pcDNA5/FRT/TO-CXCR4 were detached using trypsin and incubated with 5 nM SDF-1(67-AF488) or TY14003 in 500 μL of PBS containing 1% BSA at 0°C for 20 min in the presence of TF14016 [9], FC131 [10] or AMD3100 [27] as an inhibitor. After the incubation, the cells were analyzed using a FACSCalibur (BD Biosciences). Ten thousand events on probe-binding cells were analyzed per sample, and the data were collected from FL1 in the log mode.
The numbers of stained cells were plotted for each competitor concentration. Data were analyzed using CellQuest Pro software (BD Biosciences).
Confocal Microscopy Analyses of Ligand Internalization
CHO cells (with or without transfection) were plated on 35-mm glass-bottomed dishes and cultured in F-12 medium containing 10% heat-inactivated fetal bovine serum supplemented with penicillin/streptomycin and hygromycin. Cells were washed once with cold F-12 medium, and incubated with fluorescent ligands [SDF-1(67-AF488) or SDF-1(67-TMR) (100 nM)] in F-12
The binding affinities of the SDF-1 derivatives were evaluated as their inhibitory potencies toward [ 125 I]-SDF-1-binding to CXCR4 (Table 1) . The bioactivity of SDF-1(N-FL) was significantly less potent compared with unlabeled SDF-1. Four SDF-1 derivatives with modification at the C-terminal region [SDF-1(63-AF488), SDF-1(67-AF488), SDF-1(63-TMR) and SDF-1(67-TMR)] exhibited equipotent activities to unlabeled SDF-1, regardless of the fluorophores, consistent with a previous report that these regions were irrelevant to CXCR4 binding [30, 31] . Modification of the central -sheet region with TMR [SDF-1(27-TMR)] led to a slight decrease in the binding affinity for CXCR4, while the precursor propargyl analog [SDF-1(27-Pra)] exhibited equipotent activity to unlabeled SDF-1. Although a direct interaction of the central region of SDF-1 with CXCR4 has not been reported, the iminium cation or bulky chromophore group of TMR may interfere with the possible interaction between SDF-1 and CXCR4 [33] .
In addition, we investigated the binding affinities of the SDF-1 derivatives for CXCR7, which is known to be an alternative receptor for SDF-1 [14] . Similar to the case for CXCR4 binding, a significant decrease in the receptor binding of N-terminally modified SDF-1(N-FL) was observed, suggesting that the SDF-1 N-terminus is critical for the receptor binding to CXCR7 as well.
Modification at the central region [SDF-1(27-TMR)] also significantly decreased the bioactivity for CXCR7. In contrast, replacement of Lys27 with Pra [SDF-1(27-Pra)] did not affect the bioactivity, although a lower number of positively charged residues in SDF-1 was reported to reduce CXCR7 binding [34] . These findings suggest that the introduction of a fluorophore functional group into the central region impairs the interaction with CXCR7. The fluorescent SDF-1 derivatives with C-terminal modification [SDF-1(63-AF488), SDF-1(67-AF488), SDF-1(63-TMR) and SDF-1(67-TMR)] reproduced the binding affinity for CXCR7. This is the first report on fluorescent probes for CXCR7, which would be applicable to further investigations of SDF-1/CXCR7 signaling.
Ca

2+ Mobilization and Receptor Internalization of CXCR4-expressing Cells by Fluorescent
SDF-1 Derivatives
CXCR4-mediated Ca
2+
mobilization by the SDF-1 derivatives was evaluated using aequorin-mediated bioluminescence. SDF-1(27-TMR) showed moderate agonistic activity for CXCR4, while the fluorescent SDF-1 derivatives with C-terminal modification were almost equipotent to unlabeled SDF-1 (Figure 2 ). This result indicated that the fluorescent labeling at the C-terminus did not impair the agonistic activity via G protein-dependent signaling.
It has been reported that CXCR4 and CXCR7 are internalized by stimulation by SDF-1 [14, 21] .
To demonstrate translocation of fluorescent SDF-1 derivatives upon receptor binding, CXCR4-expressing CHO cells were treated with SDF-1(67-AF488) and SDF-1(67-TMR). The internalization of SDF-1 into CXCR4-expressing cells with both fluorescent SDF-1 derivatives after 30 min incubation at 37 °C were observed, whereas non-transfected CHO cells were not stained (Figure 3 ) [35] . In addition, internalization of the fluorescent SDF-1 derivatives in CXCR7-expressing CHO cells was also observed (Figure 3 ). Taken together, it was demonstrated that these fluorescent SDF-1 derivatives reproduced the bioactivities of intact SDF-1.
Application of the Fluorescent SDF-1 Derivatives to Flow Cytometry
The potent SDF-1(67-AF488) was applied to flow cytometry analysis of CXCR4-expressing cells. Incubation of the cells with SDF-1(67-AF488) resulted in a concentration-dependent increase in the fluorescence intensity (data not shown). When SDF-1(67-AF488) (5 nM) and the cells were incubated in the presence of a known CXCR4 antagonist, TF14016, FC131 or AMD3100, the binding of SDF-1(67-AF488) to the cells was inhibited in a concentration-dependent manner ( Figure   4 , Supplemental Figures 2 and 3 ). More potent binding inhibition was observed for TF14016 than for FC131, as previously reported [9, 10] . Of note, the inhibitory concentrations in these assays were similar to those in the flow cytometry analyses using an antagonist-based CXCR4 probe TY14003
[11], rather than the standard binding inhibition assays using the radioligand [ 125 I]-SDF-1 ( Figure 4 and Table 2 ).
Conclusions
We have established a preparation protocol for fluorescent SDF-1 derivatives via standard  A novel assay system for CXCR4 ligands by flow cytometry has been established using this fluorescent SDF-1 derivative.
 A fluorescent SDF-1 derivative has been applied to CXCR4/CXCR7 labeling and utilized as a probe in binding inhibition assays.
Future perspective
The labelled signalling molecule constitutes an important tool for biochemical studies of a receptor which is relevant to a number of disease states both in clinical use and in further clinical trials for other applications. Using the agonist-based fluorescent CXCR4 probes developed in this study, the physiological and pathological significance of CXCR4/SDF-1 signaling will be further Cells were treated with SDF-1(67-AF488) (a,c,e) or SDF-1(67-TMR) (b,d,f) (100 nM) for 30 min at 37 °C. 
